Veracyte, Inc (VCYT) Covered Calls

Veracyte, Inc covered calls Veracyte Inc is engaged in the discovery, development and commercialization of molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient treatment.

You can sell covered calls on Veracyte, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VCYT (prices last updated Fri 4:16 PM ET):

Veracyte, Inc (VCYT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
29.85 +0.34 29.00 40.50 404K -21.9 1.2B
Covered Calls For Veracyte, Inc (VCYT)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 30 1.75 38.75 -22.6% -284.4%
Sep 20 30 2.85 37.65 -20.3% -115.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Veracyte, Inc. is a molecular diagnostics company. The company discovers, develops and commercializes molecular diagnostic solutions that enable physicians to make more informed treatment decisions early. Its first commercial solution is Afirma Thyroid FNA Analysis, which specializes in cytopathology assessment with the afirma gene expression classifier, a genomic test that clarifies inconclusive thyroid nodule results as benign or suspicious for cancer. The company was founded by Bonnie H. Anderson and Doug Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.